TXMD Stock Summary and Trading Ideas (Therapeuticsmd | NASDAQ:TXMD)

TherapeuticsMD Inc is a pharmaceutical royalty company that owns and manages intellectual property, including trademarks and product rights, which are licensed to third-party pharmaceutical companies. The company generates revenue mainly through royalties and milestone payments from licensed products, including IMVEXXY, BIJUVA, and ANNOVERA, and does not directly manufacture or market pharmaceutical products.

Therapeuticsmd trades on the NASDAQ stock market under the symbol TXMD.

As of April 23, 2026, TXMD stock price climbed to $2.18 with 8,730 million shares trading.

TXMD has a beta of 0.92, meaning it tends to be less sensitive to market movements. TXMD has a correlation of 0.03 to the broad based SPY ETF.

TXMD has a market cap of $25.23 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, TXMD traded as high as $4.73 and as low as $.70.

The top ETF exchange traded funds that TXMD belongs to (by Net Assets): VTI, VXF, DFAC.

TXMD has outperformed the market in the last year with a price return of +96.4% while the SPY ETF gained +35.8%. However, in the short term, TXMD had mixed performance relative to the market. It has underperformed in the last 3 months, returning -14.5% vs +3.1% return in SPY. But in the last 2 weeks, TXMD shares have fared better than the market returning +6.3% compared to SPY +4.8%.

TXMD support price is $1.99 and resistance is $2.23 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TXMD shares will trade within this expected range on the day.